Lh. Mckinlay et al., THE ROLE OF ETS-1 IN MAST-CELL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR EXPRESSION AND ACTIVATION, The Journal of immunology (1950), 161(8), 1998, pp. 4098-4105
Ets-1 is a transcription fatter with restricted expression in lymphocy
tes, and it has been implicated in the regulation of T cell genes such
as TCR alpha, TCR beta, CD4, IL-2, and TNF-alpha. We show in this stu
dy that Ets-1 is also expressed in some mast cells constitutively and
can he induced in primary mast cells with stimuli that activate mast c
ells. We also show that Ets-l plays a role in the regulation of granul
ocyte-macrophage CSF (GM-CSF), a cytokine expressed by activated mast
cells. We have characterized a murine growth factor-independent mast c
ell line, FMP6-, derived from a factor-dependent cell line, FMP1,6, FM
P6- has acquired a distinct connective tissue mast cell-like phenotype
, as characterized by the expression of mast cell proteases MMCP-4 and
MMCP-6, expression of IL-12, anal the down-regulation of IL-4. The pa
rental FMP1.6 cell line displays a mucosal mast cell-like phenotype. F
MP6- cells have increased Ets-l expression and achieve growth-factor i
ndependence by the autocrine production of GM-CSF and IL-3. Transient
transfection of an Ets-l expression construct in FMP6- cells results i
n transactivation of a GM-CSF reporter, while a point mutation in the
consensus Ets binding site in the conserved lymphokine element, CLE0,
abolishes Ets-1 transactivation, Importantly, antisense Ets-1 demonstr
ates an ability to repress the activity of the GM-CSF reporter. These
data suggest a role for Ets-1 in mast cell growth regulation and activ
ation, and because of the central role of mast cells in inflammatory p
rocesses, such as asthma and rheumatoid arthritis, they identify Ets-l
as potentially contributing to the pathophysiology of such diseases.